Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deutsche Telekom is one of the world’s leading integrated telecommunications companies. While not itself a life sciences or pharmaceutical company, it has developed digital platforms and IoT solutions that support pharmaceutical R&D and supply chains. Notably, it co-developed the TrialComplete Early Phase eSource system with Boehringer Ingelheim to digitize data collection in Phase I clinical trials. It also collaborates on private 5G networks tailored to pharma manufacturing/logistics environments and offers unit-level tracking devices using its nuSIM technology for the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deutsche Telekom.